{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:57:09Z","timestamp":1773939429008,"version":"3.50.1"},"reference-count":44,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.1536\/ihj.20-384","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T22:15:44Z","timestamp":1610748944000},"page":"162-170","source":"Crossref","is-referenced-by-count":9,"title":["Angiotensin II Increases HMGB1 Expression in the Myocardium Through AT1 and AT2 Receptors When Under Pressure Overload"],"prefix":"10.1536","volume":"62","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University"},{"name":"Shanghai Institute of Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University"},{"name":"Shanghai Institute of Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of General Practice, Zhongshan Hospital, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University"},{"name":"Shanghai Institute of Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University"},{"name":"Shanghai Institute of Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangang","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University"},{"name":"Shanghai Institute of Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University"},{"name":"Shanghai Institute of Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzeng","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University"},{"name":"Shanghai Institute of Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University"},{"name":"Shanghai Institute of Cardiovascular Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kumar S, Wang G, Zheng N, <i>et al<\/i>. HIMF (hypoxia-induced mitogenic factor) -IL (interleukin) -6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fibrosis. Hypertension 2019; 73: 1058-70.","DOI":"10.1161\/HYPERTENSIONAHA.118.12267"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zablocki D, Sadoshima J. Solving the cardiac hypertrophy riddle: The angiotensin II-mechanical stress connection. Circ Res 2013; 113: 1192-5.","DOI":"10.1161\/CIRCRESAHA.113.302501"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Matsushita N, Ishida N, Ibi M, <i>et al<\/i>. Chronic pressure overload induces cardiac hypertrophy and fibrosis via increases in SGLT1 and IL-18 gene expression in mice. Int Heart J 2018; 59: 1123-33.","DOI":"10.1536\/ihj.17-565"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Blaustein MP. How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na+ pumps are crucial. Am J Physiol Heart Circ Physiol 2017; 313: H919-30.","DOI":"10.1152\/ajpheart.00131.2017"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gesmundo I, Miragoli M, Carullo P, <i>et al<\/i>. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure. Proc Natl Acad Sci U S A 2017; 114: 12033-8.","DOI":"10.1073\/pnas.1712612114"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Geraets IME, Glatz JFC, Luiken JJFP, Nabben M. Pivotal role of membrane substrate transporters on the metabolic alterations in the pressure-overloaded heart. Cardiovasc Res 2019; 115: 1000-12.","DOI":"10.1093\/cvr\/cvz060"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gibb AA, Hill BG. Metabolic coordination of physiological and pathological cardiac remodeling. Circ Res 2018; 123: 107-28.","DOI":"10.1161\/CIRCRESAHA.118.312017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Xu D, Zhao Y, Weng X, <i>et al<\/i>. Novel role of mitochondrial GTPases 1 in pathological cardiac hypertrophy. J Mol Cell Cardiol 2019; 128: 105-16.","DOI":"10.1016\/j.yjmcc.2019.01.025"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wang Y, Sano S, Oshima K, <i>et al<\/i>. Wnt5a-mediated neutrophil recruitment has an obligatory role in pressure overload-induced cardiac dysfunction. Circulation 2019; 140: 487-99.","DOI":"10.1161\/CIRCULATIONAHA.118.038820"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Honsho S, Nishikawa S, Amano K, <i>et al<\/i>. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Circ Res 2009; 105: 1149-58.","DOI":"10.1161\/CIRCRESAHA.109.208199"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhao L, Cheng G, Jin R, <i>et al<\/i>. Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction. Circ Res 2016; 118: 1918-29.","DOI":"10.1161\/CIRCRESAHA.116.308688"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Deng M, Tang Y, Li W, <i>et al<\/i>. The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis. Immunity 2018; 49: 740-53.e7.","DOI":"10.1016\/j.immuni.2018.08.016"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liu M, Yu Y, Jiang H, <i>et al<\/i>. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE (\u2212\/\u2212) mice by downregulating the HMGB1-RAGE axis. Acta Pharmacol Sin 2013; 34: 830-6.","DOI":"10.1038\/aps.2013.8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bangert A, Andrassy M, M\u00fcller AM, <i>et al<\/i>. Critical role of RAGE and HMGB1 in inflammatory heart disease. Proc Natl Acad Sci U S A 2016; 113: E155-64.","DOI":"10.1073\/pnas.1522288113"},{"key":"15","unstructured":"15. Su FF, Shi MQ, Guo WG, <i>et al<\/i>. High-mobility group box 1 induces calcineurin-mediated cell hypertrophy in neonatal rat ventricular myocytes. Mediators Inflamm 2012; 2012: 805149."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhang L, Liu M, Jiang H, <i>et al<\/i>. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure. J Cell Mol Med 2016; 20: 459-70.","DOI":"10.1111\/jcmm.12743"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang L, Yang X, Jiang G, <i>et al<\/i>. HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE\/ERK1\/2 signaling pathway. Int J Mol Med 2019; 44: 885-92.","DOI":"10.3892\/ijmm.2019.4276"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 2008; 29: 367-74.","DOI":"10.1016\/j.tips.2008.05.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Funayama A, Shishido T, Netsu S, <i>et al<\/i>. Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure. Cardiovasc Res 2013; 99: 657-64.","DOI":"10.1093\/cvr\/cvt128"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zhou S, Lu H, Chen R, <i>et al<\/i>. Angiotensin II enhances the acetylation and release of HMGB1 in RAW264.7 macrophage. Cell Biol Int 2018; 42: 1160-9.","DOI":"10.1002\/cbin.10984"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rompe F, Unger T, Steckelings UM. The angiotensin AT2 receptor in inflammation. Drug News Perspect 2010; 23: 104-11.","DOI":"10.1358\/dnp.2010.23.2.1475901"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hagiwara S, Iwasaka H, Hidaka S, Hasegawa A, Koga H, Noguchi T. Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats. Intensive Care Med 2009; 35: 1471-8.","DOI":"10.1007\/s00134-009-1545-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Haraguchi T, Takasaki K, Naito T, <i>et al<\/i>. Cerebroprotective action of telmisartan by inhibition of macrophages\/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Neurosci Lett 2009; 464: 151-5.","DOI":"10.1016\/j.neulet.2009.08.043"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kato Y, Kamiya H, Koide N, <i>et al<\/i>. Irbesartan attenuates production of high-mobility group box 1 in response to lipopolysaccharide via downregulation of interferon-beta production. Int Immunopharmacol 2015; 26: 97-102.","DOI":"10.1016\/j.intimp.2015.03.015"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zou Y, Li J, Ma H, <i>et al<\/i>. Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice. J Mol Cell Cardiol 2011; 51: 821-9.","DOI":"10.1016\/j.yjmcc.2011.07.030"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ling S, Sun Q, Li Y, <i>et al<\/i>. CKIP-1 inhibits cardiac hypertrophy by regulating class II histone deacetylase phosphorylation through recruiting PP2A. Circulation 2012; 126: 3028-40.","DOI":"10.1161\/CIRCULATIONAHA.112.102780"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yu Y, Liu M, Zhang L, <i>et al<\/i>. Heat shock transcription factor 1 inhibits H<sub>2<\/sub>O<sub>2<\/sub>-induced cardiomyocyte death through suppression of high-mobility group box 1. Mol Cell Biochem 2012; 364: 263-9.","DOI":"10.1007\/s11010-012-1226-x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bertagnolli M, Dios A, B\u00e9land-Bonenfant S, <i>et al<\/i>. Activation of the cardiac renin-angiotensin system in high oxygen-exposed newborn rats: Angiotensin receptor blockade prevents the developmental programming of cardiac dysfunction. Hypertension 2016; 67: 774-82.","DOI":"10.1161\/HYPERTENSIONAHA.115.06745"},{"key":"29","unstructured":"29. Januzzi JL Jr., Prescott MF, Butler J, <i>et al<\/i>. Association of Change in N-terminal pro-B-type natriuretic peptide following initiation of Sacubitril-Valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction. JAMA 2019; 322: 1-11."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Li L, Zhou N, Gong H, <i>et al<\/i>. Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertens Res 2010; 33: 1289-97.","DOI":"10.1038\/hr.2010.182"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Castoldi G, di Gioia CRT, Roma F, <i>et al<\/i>. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats. Acta Diabetol 2019; 56: 97-104.","DOI":"10.1007\/s00592-018-1220-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Carneiro-Ramos MS, Diniz GP, Nadu AP, <i>et al<\/i>. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol 2010; 105: 325-35.","DOI":"10.1007\/s00395-010-0089-0"},{"key":"33","unstructured":"33. Garg M, Royce SG, Tikellis C, <i>et al<\/i>. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: A novel therapeutic target? Gut 2020; 69: 841-51."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kr\u00f6ller-Sch\u00f6n S, Jansen T, Tran TLP, <i>et al<\/i>. Endothelial alpha1AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction. Basic Res Cardiol 2019; 114: 8.","DOI":"10.1007\/s00395-019-0717-2"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pickering RJ, Tikellis C, Rosado CJ, <i>et al<\/i>. Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. J Clin Invest 2019; 129: 406-21.","DOI":"10.1172\/JCI99987"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kamo T, Akazawa H, Komuro I. Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circ Res 2015; 117: 89-98.","DOI":"10.1161\/CIRCRESAHA.117.305349"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Akazawa H, Zou Y, Komuro I. A novel mechanism of mechanical stress-induced hypertrophy. Novartis Found Symp 2006; 274: 20-31; discussion 31.","DOI":"10.1002\/0470029331.ch3"},{"key":"38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","year":"1999","unstructured":"38. Wang H, Bloom O, Zhang M, <i>et al<\/i>. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-51.","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Guo F, Chen XL, Wang F, Liang X, Sun YX, Wang YJ. Role of angiotensin II type 1 receptor in angiotensin II-induced cytokine production in macrophages. J Interferon Cytokine Res 2011; 31: 351-61.","DOI":"10.1089\/jir.2010.0073"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Liu Y, Lu H, Zhang C, Hu J, Xu D. Recent advances in understanding the roles of T cells in pressure overload-induced cardiac hypertrophy and remodeling. J Mol Cell Cardiol 2019; 129: 293-302.","DOI":"10.1016\/j.yjmcc.2019.01.005"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Song L, Wang L, Li F, <i>et al<\/i>. Bone marrow-derived tenascin-C attenuates cardiac hypertrophy by controlling inflammation. J Am Coll Cardiol 2017; 70: 1601-15.","DOI":"10.1016\/j.jacc.2017.07.789"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 2018; 15: 387-407.","DOI":"10.1038\/s41569-018-0007-y"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol 2015; 16: 448-57.","DOI":"10.1038\/ni.3153"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Sun M, Chen M, Dawood F, <i>et al<\/i>. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 2007; 115: 1398-407.","DOI":"10.1161\/CIRCULATIONAHA.106.643585"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-384\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T21:47:09Z","timestamp":1670795229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-384\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-384","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}